Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates

Opioids provide pain relief but are associated with several adverse effects. Researchers are exploring cannabis-based medicine as an alternative. However, little is known about the tendency for physical dependence on cannabinoids in comparison with that on opioids in primates. The aim of this study...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuropharmacology 2023-02, Vol.223, p.109328-109328, Article 109328
Hauptverfasser: Ding, Huiping, Kiguchi, Norikazu, Mabry, Kelsey M., Kishioka, Shiroh, Ko, Mei-Chuan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 109328
container_issue
container_start_page 109328
container_title Neuropharmacology
container_volume 223
creator Ding, Huiping
Kiguchi, Norikazu
Mabry, Kelsey M.
Kishioka, Shiroh
Ko, Mei-Chuan
description Opioids provide pain relief but are associated with several adverse effects. Researchers are exploring cannabis-based medicine as an alternative. However, little is known about the tendency for physical dependence on cannabinoids in comparison with that on opioids in primates. The aim of this study was to compare the potency of heroin and delta-9-tetrahydrocannabinol (THC) in eliciting analgesic effects and the development of physical dependence between opioids and cannabinoids in both male and female rhesus monkeys. Systemic administration of either heroin (0.03–0.18 mg/kg) or THC (0.3–1.8 mg/kg) in a dose-dependent manner produced antinociceptive effects against an acute thermal nociceptive stimulus. The μ-opioid receptor antagonist naltrexone (0.01 mg/kg) and the cannabinoid receptor antagonist SR141716A (0.3 mg/kg) produced the same degree of rightward shift in the dose-response curves for heroin- and THC-induced antinociception, respectively. Monkeys implanted with telemetry devices were subjected to short-term repeated administrations (two injections per day for 1–3 days) of either heroin (0.18 mg/kg), morphine (1.8 mg/kg), THC (1.8 mg/kg), or CP 55,940 (0.032 mg/kg). Administration of naltrexone (0.01 mg/kg) increased respiration, heart rate, and blood pressure in heroin- or morphine-treated monkeys. In contrast, administration of SR141716A (0.3 mg/kg) did not cause a significant change in these physiological parameters in THC- or CP 55,940-treated monkeys. Additionally, morphine, but not CP 55,940, enhanced the monkeys’ hypersensitivity to the algogen capsaicin. Collectively, these results demonstrate that in nonhuman primates, both opioids and cannabinoids exert comparable antinociception; however, physical dependence on opioids, but not cannabinoids, at their antinociceptive doses, occurs following short-term exposures. •Both opioids and cannabinoids exert comparable antinociception in nonhuman primates.•Primates develop physical dependence on opioids rapidly after a short-term exposure.•Unlike opioids, short-term exposure to cannabinoids does not lead to physical dependence.•Morphine, but not CP 55,940, induces pain hypersensitivity after a 1-day exposure.
doi_str_mv 10.1016/j.neuropharm.2022.109328
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2735870507</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0028390822003872</els_id><sourcerecordid>2735870507</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-42388d1e1d2dd3ff675ab0904d713967e122f5238a3ed79c5b7ee328808f55a3</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhq2qqGyBv1D52Eu2YzuJnWOLCq2ExIW75dgTrVcbO_UkqPx7sizQY08jjZ75eB_GuICtANF-228TLiVPO1fGrQQp13anpPnANsJoVWlo649sAyBNpTow5-wz0R4AaiPMJ3auWtW0ndIb1t8syc8xJ3fgPifCPwsmj8TzwGmXy1zNWEaOf6dMS0E-Z56nmGMg_oiFFuLepeT6mF56MfGU024ZXeJTiaObkS7Z2eAOhFev9YI93Px8uP5V3d3f_r7-flf5uoO5qqUyJggUQYaghqHVjeuhgzpoobpWo5ByaFbIKQy6802vEdfMBszQNE5dsK-ntVPJawia7RjJ4-HgEuaFrNSqMRoa0CtqTqgvmajgYF9-LU9WgD0Ktnv7T7A9CrYnwevol9crSz9ieB98M7oCP04ArlEfIxZLPh6VhljQzzbk-P8rz64Yk64</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2735870507</pqid></control><display><type>article</type><title>Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ding, Huiping ; Kiguchi, Norikazu ; Mabry, Kelsey M. ; Kishioka, Shiroh ; Ko, Mei-Chuan</creator><creatorcontrib>Ding, Huiping ; Kiguchi, Norikazu ; Mabry, Kelsey M. ; Kishioka, Shiroh ; Ko, Mei-Chuan</creatorcontrib><description>Opioids provide pain relief but are associated with several adverse effects. Researchers are exploring cannabis-based medicine as an alternative. However, little is known about the tendency for physical dependence on cannabinoids in comparison with that on opioids in primates. The aim of this study was to compare the potency of heroin and delta-9-tetrahydrocannabinol (THC) in eliciting analgesic effects and the development of physical dependence between opioids and cannabinoids in both male and female rhesus monkeys. Systemic administration of either heroin (0.03–0.18 mg/kg) or THC (0.3–1.8 mg/kg) in a dose-dependent manner produced antinociceptive effects against an acute thermal nociceptive stimulus. The μ-opioid receptor antagonist naltrexone (0.01 mg/kg) and the cannabinoid receptor antagonist SR141716A (0.3 mg/kg) produced the same degree of rightward shift in the dose-response curves for heroin- and THC-induced antinociception, respectively. Monkeys implanted with telemetry devices were subjected to short-term repeated administrations (two injections per day for 1–3 days) of either heroin (0.18 mg/kg), morphine (1.8 mg/kg), THC (1.8 mg/kg), or CP 55,940 (0.032 mg/kg). Administration of naltrexone (0.01 mg/kg) increased respiration, heart rate, and blood pressure in heroin- or morphine-treated monkeys. In contrast, administration of SR141716A (0.3 mg/kg) did not cause a significant change in these physiological parameters in THC- or CP 55,940-treated monkeys. Additionally, morphine, but not CP 55,940, enhanced the monkeys’ hypersensitivity to the algogen capsaicin. Collectively, these results demonstrate that in nonhuman primates, both opioids and cannabinoids exert comparable antinociception; however, physical dependence on opioids, but not cannabinoids, at their antinociceptive doses, occurs following short-term exposures. •Both opioids and cannabinoids exert comparable antinociception in nonhuman primates.•Primates develop physical dependence on opioids rapidly after a short-term exposure.•Unlike opioids, short-term exposure to cannabinoids does not lead to physical dependence.•Morphine, but not CP 55,940, induces pain hypersensitivity after a 1-day exposure.</description><identifier>ISSN: 0028-3908</identifier><identifier>EISSN: 1873-7064</identifier><identifier>DOI: 10.1016/j.neuropharm.2022.109328</identifier><identifier>PMID: 36356937</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Analgesics, Opioid - pharmacology ; Animals ; Antinociception ; Cannabinoid Receptor Agonists - pharmacology ; Cannabinoids - pharmacology ; CP 55,940 ; Dose-Response Relationship, Drug ; Dronabinol - pharmacology ; Female ; Heroin ; Heroin - pharmacology ; Hypersensitivity ; Male ; Morphine ; Morphine - pharmacology ; Naltrexone - pharmacology ; Physical dependence ; Rimonabant ; THC</subject><ispartof>Neuropharmacology, 2023-02, Vol.223, p.109328-109328, Article 109328</ispartof><rights>2022 Elsevier Ltd</rights><rights>Copyright © 2022 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-42388d1e1d2dd3ff675ab0904d713967e122f5238a3ed79c5b7ee328808f55a3</citedby><cites>FETCH-LOGICAL-c490t-42388d1e1d2dd3ff675ab0904d713967e122f5238a3ed79c5b7ee328808f55a3</cites><orcidid>0000-0001-5783-0759</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.neuropharm.2022.109328$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,45974</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36356937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ding, Huiping</creatorcontrib><creatorcontrib>Kiguchi, Norikazu</creatorcontrib><creatorcontrib>Mabry, Kelsey M.</creatorcontrib><creatorcontrib>Kishioka, Shiroh</creatorcontrib><creatorcontrib>Ko, Mei-Chuan</creatorcontrib><title>Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates</title><title>Neuropharmacology</title><addtitle>Neuropharmacology</addtitle><description>Opioids provide pain relief but are associated with several adverse effects. Researchers are exploring cannabis-based medicine as an alternative. However, little is known about the tendency for physical dependence on cannabinoids in comparison with that on opioids in primates. The aim of this study was to compare the potency of heroin and delta-9-tetrahydrocannabinol (THC) in eliciting analgesic effects and the development of physical dependence between opioids and cannabinoids in both male and female rhesus monkeys. Systemic administration of either heroin (0.03–0.18 mg/kg) or THC (0.3–1.8 mg/kg) in a dose-dependent manner produced antinociceptive effects against an acute thermal nociceptive stimulus. The μ-opioid receptor antagonist naltrexone (0.01 mg/kg) and the cannabinoid receptor antagonist SR141716A (0.3 mg/kg) produced the same degree of rightward shift in the dose-response curves for heroin- and THC-induced antinociception, respectively. Monkeys implanted with telemetry devices were subjected to short-term repeated administrations (two injections per day for 1–3 days) of either heroin (0.18 mg/kg), morphine (1.8 mg/kg), THC (1.8 mg/kg), or CP 55,940 (0.032 mg/kg). Administration of naltrexone (0.01 mg/kg) increased respiration, heart rate, and blood pressure in heroin- or morphine-treated monkeys. In contrast, administration of SR141716A (0.3 mg/kg) did not cause a significant change in these physiological parameters in THC- or CP 55,940-treated monkeys. Additionally, morphine, but not CP 55,940, enhanced the monkeys’ hypersensitivity to the algogen capsaicin. Collectively, these results demonstrate that in nonhuman primates, both opioids and cannabinoids exert comparable antinociception; however, physical dependence on opioids, but not cannabinoids, at their antinociceptive doses, occurs following short-term exposures. •Both opioids and cannabinoids exert comparable antinociception in nonhuman primates.•Primates develop physical dependence on opioids rapidly after a short-term exposure.•Unlike opioids, short-term exposure to cannabinoids does not lead to physical dependence.•Morphine, but not CP 55,940, induces pain hypersensitivity after a 1-day exposure.</description><subject>Analgesics, Opioid - pharmacology</subject><subject>Animals</subject><subject>Antinociception</subject><subject>Cannabinoid Receptor Agonists - pharmacology</subject><subject>Cannabinoids - pharmacology</subject><subject>CP 55,940</subject><subject>Dose-Response Relationship, Drug</subject><subject>Dronabinol - pharmacology</subject><subject>Female</subject><subject>Heroin</subject><subject>Heroin - pharmacology</subject><subject>Hypersensitivity</subject><subject>Male</subject><subject>Morphine</subject><subject>Morphine - pharmacology</subject><subject>Naltrexone - pharmacology</subject><subject>Physical dependence</subject><subject>Rimonabant</subject><subject>THC</subject><issn>0028-3908</issn><issn>1873-7064</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhq2qqGyBv1D52Eu2YzuJnWOLCq2ExIW75dgTrVcbO_UkqPx7sizQY08jjZ75eB_GuICtANF-228TLiVPO1fGrQQp13anpPnANsJoVWlo649sAyBNpTow5-wz0R4AaiPMJ3auWtW0ndIb1t8syc8xJ3fgPifCPwsmj8TzwGmXy1zNWEaOf6dMS0E-Z56nmGMg_oiFFuLepeT6mF56MfGU024ZXeJTiaObkS7Z2eAOhFev9YI93Px8uP5V3d3f_r7-flf5uoO5qqUyJggUQYaghqHVjeuhgzpoobpWo5ByaFbIKQy6802vEdfMBszQNE5dsK-ntVPJawia7RjJ4-HgEuaFrNSqMRoa0CtqTqgvmajgYF9-LU9WgD0Ktnv7T7A9CrYnwevol9crSz9ieB98M7oCP04ArlEfIxZLPh6VhljQzzbk-P8rz64Yk64</recordid><startdate>20230201</startdate><enddate>20230201</enddate><creator>Ding, Huiping</creator><creator>Kiguchi, Norikazu</creator><creator>Mabry, Kelsey M.</creator><creator>Kishioka, Shiroh</creator><creator>Ko, Mei-Chuan</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5783-0759</orcidid></search><sort><creationdate>20230201</creationdate><title>Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates</title><author>Ding, Huiping ; Kiguchi, Norikazu ; Mabry, Kelsey M. ; Kishioka, Shiroh ; Ko, Mei-Chuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-42388d1e1d2dd3ff675ab0904d713967e122f5238a3ed79c5b7ee328808f55a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Analgesics, Opioid - pharmacology</topic><topic>Animals</topic><topic>Antinociception</topic><topic>Cannabinoid Receptor Agonists - pharmacology</topic><topic>Cannabinoids - pharmacology</topic><topic>CP 55,940</topic><topic>Dose-Response Relationship, Drug</topic><topic>Dronabinol - pharmacology</topic><topic>Female</topic><topic>Heroin</topic><topic>Heroin - pharmacology</topic><topic>Hypersensitivity</topic><topic>Male</topic><topic>Morphine</topic><topic>Morphine - pharmacology</topic><topic>Naltrexone - pharmacology</topic><topic>Physical dependence</topic><topic>Rimonabant</topic><topic>THC</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ding, Huiping</creatorcontrib><creatorcontrib>Kiguchi, Norikazu</creatorcontrib><creatorcontrib>Mabry, Kelsey M.</creatorcontrib><creatorcontrib>Kishioka, Shiroh</creatorcontrib><creatorcontrib>Ko, Mei-Chuan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neuropharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ding, Huiping</au><au>Kiguchi, Norikazu</au><au>Mabry, Kelsey M.</au><au>Kishioka, Shiroh</au><au>Ko, Mei-Chuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates</atitle><jtitle>Neuropharmacology</jtitle><addtitle>Neuropharmacology</addtitle><date>2023-02-01</date><risdate>2023</risdate><volume>223</volume><spage>109328</spage><epage>109328</epage><pages>109328-109328</pages><artnum>109328</artnum><issn>0028-3908</issn><eissn>1873-7064</eissn><abstract>Opioids provide pain relief but are associated with several adverse effects. Researchers are exploring cannabis-based medicine as an alternative. However, little is known about the tendency for physical dependence on cannabinoids in comparison with that on opioids in primates. The aim of this study was to compare the potency of heroin and delta-9-tetrahydrocannabinol (THC) in eliciting analgesic effects and the development of physical dependence between opioids and cannabinoids in both male and female rhesus monkeys. Systemic administration of either heroin (0.03–0.18 mg/kg) or THC (0.3–1.8 mg/kg) in a dose-dependent manner produced antinociceptive effects against an acute thermal nociceptive stimulus. The μ-opioid receptor antagonist naltrexone (0.01 mg/kg) and the cannabinoid receptor antagonist SR141716A (0.3 mg/kg) produced the same degree of rightward shift in the dose-response curves for heroin- and THC-induced antinociception, respectively. Monkeys implanted with telemetry devices were subjected to short-term repeated administrations (two injections per day for 1–3 days) of either heroin (0.18 mg/kg), morphine (1.8 mg/kg), THC (1.8 mg/kg), or CP 55,940 (0.032 mg/kg). Administration of naltrexone (0.01 mg/kg) increased respiration, heart rate, and blood pressure in heroin- or morphine-treated monkeys. In contrast, administration of SR141716A (0.3 mg/kg) did not cause a significant change in these physiological parameters in THC- or CP 55,940-treated monkeys. Additionally, morphine, but not CP 55,940, enhanced the monkeys’ hypersensitivity to the algogen capsaicin. Collectively, these results demonstrate that in nonhuman primates, both opioids and cannabinoids exert comparable antinociception; however, physical dependence on opioids, but not cannabinoids, at their antinociceptive doses, occurs following short-term exposures. •Both opioids and cannabinoids exert comparable antinociception in nonhuman primates.•Primates develop physical dependence on opioids rapidly after a short-term exposure.•Unlike opioids, short-term exposure to cannabinoids does not lead to physical dependence.•Morphine, but not CP 55,940, induces pain hypersensitivity after a 1-day exposure.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>36356937</pmid><doi>10.1016/j.neuropharm.2022.109328</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0001-5783-0759</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0028-3908
ispartof Neuropharmacology, 2023-02, Vol.223, p.109328-109328, Article 109328
issn 0028-3908
1873-7064
language eng
recordid cdi_proquest_miscellaneous_2735870507
source MEDLINE; Elsevier ScienceDirect Journals
subjects Analgesics, Opioid - pharmacology
Animals
Antinociception
Cannabinoid Receptor Agonists - pharmacology
Cannabinoids - pharmacology
CP 55,940
Dose-Response Relationship, Drug
Dronabinol - pharmacology
Female
Heroin
Heroin - pharmacology
Hypersensitivity
Male
Morphine
Morphine - pharmacology
Naltrexone - pharmacology
Physical dependence
Rimonabant
THC
title Functional consequences of short-term exposure to opioids versus cannabinoids in nonhuman primates
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T12%3A42%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20consequences%20of%20short-term%20exposure%20to%20opioids%20versus%20cannabinoids%20in%20nonhuman%20primates&rft.jtitle=Neuropharmacology&rft.au=Ding,%20Huiping&rft.date=2023-02-01&rft.volume=223&rft.spage=109328&rft.epage=109328&rft.pages=109328-109328&rft.artnum=109328&rft.issn=0028-3908&rft.eissn=1873-7064&rft_id=info:doi/10.1016/j.neuropharm.2022.109328&rft_dat=%3Cproquest_cross%3E2735870507%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2735870507&rft_id=info:pmid/36356937&rft_els_id=S0028390822003872&rfr_iscdi=true